Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Loew

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
British Journal of Pharmacology|March 1, 1977
Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings]A L Jaton, D M Loew, J M Vigouret
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agentA M Johnson, J M Vigouret, D M Loew
British Journal of Pharmacology|January 1, 1976
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPAA M Johnson, D M Loew, J M Vigouret
Pharmacology|January 1, 1978
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712J M Vigouret, H R Bürki, A L Jaton, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
The neuroleptics. 3. Pharmacology. IntroductionJ M Van Rossum, P A Janssen, J R Boissier, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
British Journal of Pharmacology|March 1, 1977
Turning behaviour elicited by apomorphine, (+)-amphetamine and three ergot derivatives in rats treated with a unilateral injection of ethanolamine-O-sulphate in the substantia nigra [proceedings]A L Jaton, D M Loew, J M Vigouret
Naunyn-Schmiedeberg'S Archives of Pharmacology|March 22, 1974
Proceedings: CB 154 (2-bromo-alpha-ergokryptine, bromocriptin), a potential anti-Parkinson agentA M Johnson, J M Vigouret, D M Loew
British Journal of Pharmacology|January 1, 1976
Stimulant properties of bromocriptine on central dopamine receptors in comparison to apomorphine, (+)-amphetamine and L-DOPAA M Johnson, D M Loew, J M Vigouret
Pharmacology|January 1, 1978
Neurochemical and neuropharmacological investigations with four ergot derivatives: bromocriptine, dihydroergotoxine, CF 25-397 and CM 29-712J M Vigouret, H R Bürki, A L Jaton, et al.
Modern Problems of Pharmacopsychiatry|January 1, 1970
The neuroleptics. 3. Pharmacology. IntroductionJ M Van Rossum, P A Janssen, J R Boissier, et al.
Pageof 3